SMT201500039B - Uso del nifuratel per il trattamento di infenzionicausate dalle specie di clostridium - Google Patents

Uso del nifuratel per il trattamento di infenzionicausate dalle specie di clostridium

Info

Publication number
SMT201500039B
SMT201500039B SM201500039T SM201500039T SMT201500039B SM T201500039 B SMT201500039 B SM T201500039B SM 201500039 T SM201500039 T SM 201500039T SM 201500039 T SM201500039 T SM 201500039T SM T201500039 B SMT201500039 B SM T201500039B
Authority
SM
San Marino
Prior art keywords
nifuratel
treatment
infections caused
clostridium species
clostridium
Prior art date
Application number
SM201500039T
Other languages
English (en)
Italian (it)
Inventor
Federico Mailland
Anna Bulgheroni
Giuliana Iob
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of SMT201500039B publication Critical patent/SMT201500039B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SM201500039T 2011-02-22 2015-02-13 Uso del nifuratel per il trattamento di infenzionicausate dalle specie di clostridium SMT201500039B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11155283A EP2491929A1 (en) 2011-02-22 2011-02-22 Use of Nifuratel to treat infections caused by Clostridium species
PCT/EP2012/050759 WO2012113594A1 (en) 2011-02-22 2012-01-19 Use of nifuratel to treat infections caused by clostridium species

Publications (1)

Publication Number Publication Date
SMT201500039B true SMT201500039B (it) 2015-03-05

Family

ID=44059064

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500039T SMT201500039B (it) 2011-02-22 2015-02-13 Uso del nifuratel per il trattamento di infenzionicausate dalle specie di clostridium

Country Status (24)

Country Link
EP (2) EP2491929A1 (xx)
KR (1) KR20140021525A (xx)
CN (1) CN103384523B (xx)
AR (1) AR085266A1 (xx)
BR (1) BR112013015974A2 (xx)
CL (1) CL2013002098A1 (xx)
CY (1) CY1116210T1 (xx)
DK (1) DK2678015T3 (xx)
EA (1) EA025645B1 (xx)
ES (1) ES2529210T3 (xx)
GE (1) GEP20156264B (xx)
HK (1) HK1187553A1 (xx)
HR (1) HRP20150141T1 (xx)
ME (1) ME02056B (xx)
MX (1) MX341213B (xx)
PL (1) PL2678015T3 (xx)
PT (1) PT2678015E (xx)
RS (1) RS53739B1 (xx)
SI (1) SI2678015T1 (xx)
SM (1) SMT201500039B (xx)
TW (1) TWI536989B (xx)
UA (1) UA113159C2 (xx)
UY (1) UY33915A (xx)
WO (1) WO2012113594A1 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102885793B (zh) * 2012-10-15 2014-08-20 山东罗欣药业股份有限公司 一种硝呋太尔组合物片剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000255A1 (en) * 2001-06-25 2003-01-03 Essential Therapeutics, Inc. Novel nitrofuran-containing heterocyclic compounds and uses thereof
EP2243482A1 (en) 2009-04-20 2010-10-27 Polichem SA Use of nifuratel to treat infections caused by atopobium species

Also Published As

Publication number Publication date
PT2678015E (pt) 2015-02-10
WO2012113594A1 (en) 2012-08-30
UY33915A (es) 2012-04-30
UA113159C2 (xx) 2016-12-26
RS53739B1 (en) 2015-06-30
MX341213B (es) 2016-08-11
CN103384523A (zh) 2013-11-06
TW201309292A (zh) 2013-03-01
PL2678015T3 (pl) 2015-04-30
CL2013002098A1 (es) 2014-06-06
DK2678015T3 (en) 2015-01-26
EA201370179A1 (ru) 2014-03-31
SI2678015T1 (sl) 2015-03-31
EP2491929A1 (en) 2012-08-29
AR085266A1 (es) 2013-09-18
CN103384523B (zh) 2015-04-29
ES2529210T3 (es) 2015-02-18
MX2013009686A (es) 2013-12-06
EA025645B1 (ru) 2017-01-30
GEP20156264B (en) 2015-03-25
BR112013015974A2 (pt) 2018-06-05
EP2678015A1 (en) 2014-01-01
EP2678015B1 (en) 2014-11-26
ME02056B (me) 2015-05-20
HK1187553A1 (en) 2014-04-11
TWI536989B (zh) 2016-06-11
KR20140021525A (ko) 2014-02-20
HRP20150141T1 (xx) 2015-03-13
CY1116210T1 (el) 2017-02-08

Similar Documents

Publication Publication Date Title
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
CY2019015I2 (el) Χρηση πυριτικου ζιρκονιου για τη θεραπεια της υπερκαλιαιμιας
ZA201506916B (en) Microstructure array for delivery of active agents
HK1211589A1 (en) Compounds for the treatment of paramoxyvirus viral infections
CL2015000873A1 (es) Métodos para el tratamiento del síndrome de alport.
DK2793794T3 (da) Håndfri krykke
DK2852391T3 (da) Systemer til behandling af lungeinfektioner
BR112014024373A2 (pt) anticorpos regulados por protease
DK2861214T3 (da) Tilpassede liposomer til behandling af bakterieinfektioner
SMT201500086B (it) Uso del nifuratel per il trattamento di infezioni causate dalla specie atopobium
ITRM20120601A1 (it) Formatore di spalla.
DK2925790T3 (da) Formalingsproces
ITMI20131893A1 (it) Apparecchio di pulizia
ZA201306342B (en) The treatment of viral infections
DK2734634T3 (da) Igf-1 til anvendelse til behandling af migræne
BR112013029496A2 (pt) câmara de biorreator
SMT201500039B (it) Uso del nifuratel per il trattamento di infenzionicausate dalle specie di clostridium
UY34449A (es) Composicion de limpieza
BR112014001965A2 (pt) di-cloridrato de denibulin
BR112013027413A2 (pt) vancomicina lipossomal para o tratamento de infecções de sarm.
FR2972715B1 (fr) Borne de proprete.
DE112011104700A5 (de) Schleifverfahren
FR2978026B1 (fr) Ustensile de nettoyage.
ITTO20110985A1 (it) Dispositivo di asciugatura per lavastoviglie
EE01086U1 (et) Enesemassaaživahend